Hanneken S, Poot F (2025) Umfassende Weiterbildung in Psychodermatologie: Diplomkurs der European Society for Dermatology and Psychiatry (ESDaP). [Comprehensive training in psychodermatology: the diploma course of the European Society for Dermatology and Psychiatry]. Die Dermatologie. 76(2):81-85
Sandra Hanneken (2024) Tagungsbericht der 29. Jahrestagung des Arbeitskreises Psychosomatische Dermatologie am 22. und 23.09.2023 in Bad Bentheim.JDDG 11 Januar 2024.
Hanneken S (2023) Conference Report of the 29th Annual Meeting of the Working Group Psychosomatic Dermatology on September 22-23, 2023, in Bad Bentheim, Germany.J Clin Dermatol Ther 10: 0134.
Sandra Hanneken (2022) Ambulante Psychodermatologie: Vielfältig, potentialreich und bedeutsam. Rundbrief des Arbeitskreises für Psychosomatische Dermatologie Sektion der Deutschen Dermatologischen Gesellschaft. Jahrgang 2022.
Kumar S, Borisov O, Maj C, Ralser DJ, Humbatova A, Hanneken S, Schmieder A, Groß J, Maintz L, Heineke A, Knuever J, Fagerberg C, Parmentier L, Anemüller W, Oji V, Tantcheva-Poór I, Fölster-Holst R, Wenzel J, Krawitz PM, Frank J, Betz RC (2024) Founder Variants in KRT5 and POGLUT1 are implicated in Dowling-Degos Disease.J Invest Dermatol144(1):181-184.
Biolcati G, Hanneken S, Minder EI, Neumann NJ, Wilson JHP, Wolgen PJ, Wright DJ, Lloyd AJ (2021) Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL. Patient Rep Outcomes. 15;5(1):73.
Biolcati G, Hanneken S, Minder EI, Neumann NJ, Wilson JHP, Wolgen PJ, Wright DJ, Lloyd AJ. (2021) Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL. Patient Rep Outcomes 3;5(1):65
Parren LJMT, Baron JM, Joussen 5, Marquardt Y, Hanneken S, van Steensel MAM, Steijlen PM, van Geel M2,Frank J (2018) CYLD mutations differentially affect splicing and mRNA decay in Brooke-Spiegler syndrome. J Eur Acad Dermatol Venereol. 32(8)
Fischer, J, Degenhardt, F, Hofmann, A, Redler, S, Basmanav, F, Heilmann-Heimbach, S, Hanneken, S, Giehl, K, Wolff, H, Moebus, S. , Kruse, R, Lutz, G, Blaumeiser, B, Böhm, M, Garcia Bartels, N, Blume-Peytavi, U, Pethukova, L, Christiano, A, Nöthen, M, Betz, R (2017) Genome-wide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2.Exp Dermatol Jun;26(6):536-541.
Redler S, Angisch M, Heilmann S, Wolf S, Barth S, Basmanav BF,
Giehl KA, Hanneken S, Eigelshoven S, Mangold E, Kruse R,
Blaumeiser B, Böhm M, Knapp M, Garcia Bartels N, Lutz G, Wolff
H, Blume-Peytavi U, Nöthen MM, Becker T, Betz RC (2015)
Immunochip-based analysis: high-density genotyping of
immune-related loci sheds further light on the autoimmune
genetic architecture of alopecia areata. J Invest Dermatol
135(3):919-21.
Basmanav FB, Fritz G, Lestringant GG, Pachat D, Hoffjan S,
Fischer J, Wehner M, Wolf S, Thiele H, Altmüller J, Pulimood
SA, Rütten A, Kruse R, Hanneken S, Frank J, Danda S, Bygum A,
Betz RC (2015) Pathogenicity of POFUT1 in Dowling-Degos
disease: additional mutations and clinical overlap with
reticulate acropigmentation of kitamura. J Invest Dermatol
135(2):615-8.
Verma S, Pasternack SM, Rütten A, Ruzicka T, Betz RC, Hanneken
S (2014) The First Report of KRT5 Mutation Underlying
Acantholytic Dowling-Degos Disease with Mottled
Hypopigmentation in an Indian Family. Indian J Dermatol
59(5):476-80.
Basmanav FB, Oprisoreanu AM, Pasternack SM, Thiele H, Fritz G,
Wenzel J, Größer L, Wehner M, Wolf S, Fagerberg C, Bygum A,
Altmüller J, Rütten A, Parmentier L, El Shabrawi-Caelen L,
Hafner C, Nürnberg P, Kruse R, Schoch S, Hanneken S, Betz RC
(2014) Mutations in POGLUT1, encoding protein
O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos
disease. Am J Hum Genet 2;94(1):135-43
Redler S, Dobson K, Drichel D, Heilmann S, Wolf S, Brockschmidt
FF, Tazi-Ahnini R, Birch P, Teßmann P, Giehl KA, Kruse R, Lutz
G, Garcia Bartels N, Hanneken S, Wolff H, Böhm M, Becker T,
Blume-Peytavi U, Nöthen MM, Messenger AG, Betz RC (2013)
Investigation of six novel susceptibility loci for male
androgenetic alopecia in women with female pattern hair loss. J
Dermatol Sci 72(2):186-8.
Nuwaihyd R, Redler S, Heilmann S, Drichel D, Wolf S, Birch P,
Dobson K, Lutz G, Giehl KA, Kruse R, Tazi-Ahnini R, Hanneken S,
Böhm M, Miesel A, Fischer T, Wolff H, Becker T, Garcia-Bartels
N, Blume-Peytavi U, Nöthen MM, Messenger AG, Betz RC (2014)
Investigation of four novel male androgenetic alopecia
susceptibility loci: no association with female pattern hair
loss. Arch Dermatol Res 306(4):413-8.
Forstbauer LM, Brockschmidt FF, Moskvina V, Herold C, Redler S,
Herzog A, Hillmer AM, Meesters C, Heilmann S, Albert F, Alblas
M, Hanneken S, Eigelshoven S, Giehl KA, Jagielska D,
Blume-Peytavi U, Garcia Bartels N, Kuhn J, Hennies HC, Goebeler
M, Jung A, Peitsch WK, Kortüm AK, Moll I, Kruse R, Lutz G,
Wolff H, Blaumeiser B, Böhm M, Kirov G, Becker T, Nöthen MM,
Betz RC (2012) Genome-wide pooling approach identifies SPATA5
as a new susceptibility locus for alopecia areata. Eur J Hum
Genet 20(3):326-32.
Heilmann S, Brockschmidt FF, Hillmer AM, Hanneken S,
Eigelshoven S, Ludwig KU, Herold C, Mangold E, Becker T, Kruse
R, Knapp M, Nöthen MM (2013) Evidence for a polygenic
contribution to androgenetic alopecia. Br J Dermatol
169(4):927-30.
Mahmoudi H, Redler S, Birch P, Drichel D, Dobson K, Tazi-Ahnini
R, Teßmann P, Giehl KA, Kruse R, Lutz G, Hanneken S, Wolff H,
Blume-Peytavi U, Becker T, Nöthen MM, Messenger AG, Böhm M,
Betz RC (2013) Selected variants of the melanocortin 4 receptor
gene (MC4R) do not confer susceptibility to female pattern hair
loss. Arch Dermatol Res 305(3):249-53.
Bafteh PR, Siegesmund M, Hanneken S, Neumann NJ (2012)
Protective effects of β-carotene and melanin against
protoporphyrine IX-induced phototoxicity in the photo hen's egg
test. Photodermatol Photoimmunol Photomed 28(1):12-6.
Redler S, Albert F, Brockschmidt FF, Herold C, Hanneken S,
Eigelshoven S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser
B, Böhm M, Becker T, Nöthen MM, Betz RC (2012) Investigation of
selected cytokine genes suggests that IL2RA and the TNF/LTA
locus are risk factors for severe alopecia areata. Br J
Dermatol 167(6):1360-5.
Braun SA, Hanneken S, Reifenberger J, Helbig D, Frank J (2012)
[Hereditary cutaneous leiomyomatosis]. Hautarzt
63(4):276-8.
Lichte V, Hanneken S, Gerber PA, van Geel M, Frank J. (2012)
[Facial papules and pneumothoraces. Birt-Hogg-Dubé syndrome].
Hautarzt 63(10):762-5.
Jagielska D, Redler S, Brockschmidt FF, Herold C, Pasternack
SM, Garcia Bartels N, Hanneken S, Eigelshoven S, Refke M, Barth
S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M,
Blume-Peytavi U, Becker T, Nöthen MM, Betz RC (2012) Follow-up
study of the first genome-wide association scan in alopecia
areata: IL13 and KIAA0350 as susceptibility loci supported with
genome-wide significance. J Invest Dermatol
132(9):2192-7.
Braun SA, Helbig D, Frank J, Hanneken S (2012) [Eruptive
melanocytic nevi during azathioprine therapy in myasthenia
gravis]. Hautarzt 63(10):756-9.
Katugampola RP, Anstey AV, Finlay AY, Whatley S, Woolf J, Mason
N, Deybach JC, Puy H, Ged C, de Verneuil H, Hanneken S, Minder
E, Schneider-Yin X, Badminton MN (2012) A management algorithm
for congenital erythropoietic porphyria derived from a study of
29 cases. Br J Dermatol 167(4):888-900.
Katugampola RP, Badminton MN, Finlay AY, Whatley S, Woolf J,
Mason N, Deybach JC, Puy H, Ged C, de Verneuil H, Hanneken S,
Minder E, Schneider-Yin X, Anstey AV (2012) Congenital
erythropoietic porphyria: a single-observer clinical study of
29 cases. Br J Dermatol 167(4):901-13.
Hoff NP, Reifenberger J, Schulte KW, Hanneken S (2012)
[Epithelioid sarcoma of the right hand]. Hautarzt
63(4):278-82.
Li R, Brockschmidt FF, Kiefer AK, Stefansson H, Nyholt DR, Song
K, Vermeulen SH, Kanoni S, Glass D, Medland SE, Dimitriou M,
Waterworth D, Tung JY, Geller F, Heilmann S, Hillmer AM,
Bataille V, Eigelshoven S, Hanneken S, Moebus S, Herold C, den
Heijer M, Montgomery GW, Deloukas P, Eriksson N, Heath AC,
Becker T, Sulem P, Mangino M, Vollenweider P, Spector TD,
Dedoussis G, Martin NG, Kiemeney LA, Mooser V, Stefansson K,
Hinds DA, Nöthen MM, Richards JB (2012) Six novel
susceptibility Loci for early-onset androgenetic alopecia and
their unexpected association with common diseases. PLoS Genet
8(5)
Meinhard Schiller, Claus-Detlev Klemke, Andreas Arnold, Nina
Booken, Sandra Hanneken, Erhard Hölzle, Martin Kaatz, Thomas
Schwarz, Michael Weichenthal , Uwe Hillen (2011) S1 Leitlinie -
extrakorporale Photopherese. AWMF Register Nummer 013/072
John KK, Brockschmidt FF, Redler S, Herold C, Hanneken S,
Eigelshoven S, Giehl KA, De Weert J, Lutz G, Kruse R, Wolff H,
Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC (2011)
Genetic variants in CTLA4 are strongly associated with alopecia
areata. J Invest Dermatol 131(5):1169-72.
Brockschmidt FF, Heilmann S, Ellis JA, Eigelshoven S, Hanneken
S, Herold C, Moebus S, Alblas MA, Lippke B, Kluck N, Priebe L,
Degenhardt FA, Jamra RA, Meesters C, Jöckel KH, Erbel R, Harrap
S, Schumacher J, Fröhlich H, Kruse R, Hillmer AM, Becker T,
Nöthen MM (2011) Susceptibility variants on chromosome 7p21.1
suggest HDAC9 as a new candidate gene for male-pattern
baldness. Br J Dermatol 165(6):1293-302.
Hanneken S, Rütten A, Eigelshoven S, Braun-Falco M, Pasternack
SM, Ruzicka T, Nöthen MM, Betz RC, Kruse R (2011) [Galli-Galli
disease. Clinical and histopathological investigation using a
case series of 18 patients]. Hautarzt 62(11):842-51.
Kochs C, Bockmann A, Hanneken S, Neumann NJ (2011) [Scleredema
diabeticorum: successful treatment with UVA-1 phototherapy].
Hautarzt 62(4):255-7.
Braun SA, Albrecht P, Methner A, Hanneken S. (2011) POEMS
syndrome. An interdisciplinary clinical challenge. Hautarzt
62(10):722-5.
Redler S, Kruse R, Eigelshoven S, Hanneken S, Refke M, Wen Y,
Zhang X, Cichon S, Betz RC, Nöthen MM (2010) Marie Unna
hereditary hypotrichosis: Identification of a U2HR mutation in
the family from the original 1925 report. J Am Acad Dermatol
64(4):e45-50
Redler S, Brockschmidt FF, Forstbauer L, Giehl KA, Herold C,
Eigelshoven S, Hanneken S, de Weert J, Lutz G, Wolff H, Kruse
R, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC (2010)
The TRAF/C5 locus confers risk for familial and severe alopecia
areata. Br J Dermatol 162 (4): 866-869.
Mota R, Reifenberger J, Hanneken S, Mühlenstädt E (2010)
[Classical and atypical presentations of Galli-Galli disease].
Hautarzt 61(4):284-6.
Hanneken S, Rütten A, Pasternack SM, Eigelshoven S, El
Shabrawi-Caelen L, Wenzel J, Braun-Falco M, Ruzicka T, Nöthen
MM, Kruse R, Betz RC (2010) Systematic mutation screening of
KRT5 supports the hypothesis that Galli-Galli disease is a
variant of Dowling-Degos disease. Br J Dermatol
163(1):197-200.
Brockschmidt FF, Hillmer AM, Eigelshoven S, Hanneken S,
Heilmann S, Barth S, Herold C, Becker T, Kruse R, Nöthen MM
(2010) Fine mapping of the human AR/EDA2R locus in androgenetic
alopecia. Br J Dermatol 162(4):899-903.
Hanneken S, Siegesmund M, Bolsen K, Gardlo K, Neumann NJ (2010)
The prognostic value of cord blood analysis in erythropoietic
protoporphyria:
The ‘Duesseldorf Cord Blood Study’. Photoderm Photoimmunol
Photomed 26(1):7-9.
Hoff NP, Akanay-Diesel S, Pippirs U, Schulte KW, Hanneken S
(2009) [Cutaneous side effects of hydroxyurea tretament for
polycythemia vera.] Hautarzt 60(10):783-7.
Hoff NP, Hanneken S (2009) Nebenwirkungen einer
Hydroxyurea-Therapie an der Haut. Campanile 2/2009:2-3.
Kochs C, Mühlenstädt E, Neumann NJ, Hanneken S (2009)
[Solarium-induced pseudoporphyria and variegate porphyria as
rare differential diagnoses of porphyria cutanea tarda.]
Hautarzt 60(10):790-3.
Hanneken S, Kürten V, Hörnke M, Neumann NJ (2009) Metastatic
colon cancer triggering an acute attack of variegate porphyria.
Int J Colorectal Dis 24:127-8.
Akanay-Diesel S, Richter J, Schneider M, Schulte KW,
Reifenberger J, Hanneken S (2009) [Shulman’s syndrome
(eosinophilic fasciitis)]. Hautarzt 60(4):278-81
Wessendorf U, Hanneken S, Haust M, Neumann NJ (2009) [Fixed
solar urticaria with delayed onset]. J Am Acad Dermatol
60(4):695-7.
Hillmer AM, Brockschmidt FF, Hanneken S, Eigelshoven S,
Steffens M, Flaquer A, Herms S, Becker T, Kortüm AK, Nyholt DR,
Zhao ZZ, Montgomery GW, Martin NG, Mühleisen TW, Alblas MA,
Moebus S, Jöckel KH, Bröcker-Preuss M, Erbel R, Reinartz R,
Betz RC, Cichon S, Propping P, Baur MP, Wienker TF, Kruse R,
Nöthen MM (2008) Susceptibility variants for male-pattern
baldness on chromosome 20p11. Nat Genet 40(11):1279-81.
Hanneken S, Wessendorf U, Neumann NJ (2008) Photodynamic
onycholysis: first report of photo-onycholysis after
photodynamic therapy. Clin Exp Dermatol 33(5):659-60.
Antal AS, Hanneken S, Neumann NJ, Hengge UR (2008)
[Considerable variation in the range of time for complications
to appear after tattoos.] Hautarzt 59(10):769-71.
Kochs C, Hanneken S, Schulte KW, Reifenberger J (2008)
[Treatment of carcinoma in situ of erythema ab igne with
photodynamic therapy] Hautarzt 59(10):777-9.
Hanneken S, Schulte KW, Neumann NJ (2008) [Photodynamic therapy
of granuloma annulare.] Hautarzt 59(4):283-5.
Hillmer AM, Flaquer A, Hanneken S, Eigelshoven S, Kortüm AK,
Brockschmidt FF, Golla A, Metzen C, Thiele H, Kolberg S,
Reinartz R, Betz RC, Ruzicka T, Hennies HC, Kruse R and Nöthen
MM (2008) Genome-wide scan and fine-mapping linkage study of
androgenetic alopecia reveals a locus on chromosome 3q26. Am J
Hum Genet 82(3):737-43.
Betz R, König K, Flaquer A, Redler S, Eigelhoven S, Kortüm AK,
Hanneken S, Hillmer A, Tüting T, Lambert J, De Weert J, Kruse
R, Lutz G, Blaumeiser B, Nöthen MM (2008) The R620W
polymorphism in PTPN22 confers general susceptibility for the
development of alopecia areata. Br J Dermatol
158(2):389-91.
Betz R, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelhoven S,
Kortüm AK, Tüting T, Lambert J, De Weert J, Hillmer A, Schmael
C, Wienker T, Kruse R, Lutz G, Blaumeiser B, Nöthen MM (2007)
Loss-of-function mutations in the filaggrin gene and alopecia
areata: strong risk factor for a severe course of disease in
patients comorbid for atopic disease. J Invest Dermatol
127(11):2539-43.
Planko L, Böhse K, Höfeld J, Betz R, Hanneken S, Eigelshoven S,
Kruse R, Nöthen M, Magin T (2007) Identification of a
keratin-associated protein with a putative role in vesicle
transport. Eur J Cell Biol 86(11-12):827-39.
Schafer N, Blaumeiser B, Becker T, Freudenberg-Hua Y, Hanneken
S, Eigelshoven S, Schmael C, Lambert J, De Weert J, Kruse R,
Nothen MM, Betz RC (2006) Investigation of the functional
variant c.-169T>C of the Fc receptorlike 3 (FCRL3) gene in
alopecia areata. Int J Immunogenet 33(6):393-5.
Hanneken S, Reifenberger J, Homey B (2006) [Double-lip and
blepharochalasis: Ascher syndrome in a 13 year-old female
patient.] Hautarzt 57(10):903-4.
Ritzmann S, Kruse R, Rauch L, Hanneken S, Ruzicka T, Neumann NJ
(2006) Thelalgia in man – successful treatment with botulinum
toxin. Arch Dermatol 142(9):1242-3.
Entz P, Blaumeiser B, Betz R, Lambert J, Seymons K, Eigelshoven
S, Hanneken S, Kruse R, Nurnberg P, Nagy M, Nöthen MM (2006)
Investigation of the HLA-DRB1 locus in alopecia areata. Eur J
Dermatol 16(4):363-7.
Pforr J, Blaumeiser B, Becker T, Freudenberg-Hua Y, Hanneken S,
Eigelshoven S, Cuyt I, De Weert J, Lambert J, Kruse R, Nöthen
MM & Betz RC (2006) Investigation of the p.Ser278Arg
polymorphism of the autoimmune regulator (AIRE) gene in
alopecia areata. Tissue Antigens 68:58-61.
Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann
S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J,
Lambert J, Kruse R, Nöthen MM (2006) Familial aggregation of
alopecia areata. J Am Acad Dermatol 54(4):627-32.
Hanneken S, Kürten V, Reifenberger J, Ruzicka T, Neumann NJ
(2006) [Erythropoetic protoporphyria in childhood.] Hautarzt
57(4):318-20.
Kuhn A, Hanneken S, Megahed M, Ruzicka T, Neumann NJ (2006)
[Extreme photosensitivity since childhood.] Hautarzt 57
(1):56-8.
Betz RC, Planko L, Eigelshoven S, Hanneken S, Pasternack SM,
Bussow H, Bogaert KV, Wenzel J, Braun-Falco M, Rütten A, Rogers
MA, Ruzicka T, Nöthen MM, Magin TM, Kruse R. (2006)
Loss-of-function mutations in the keratin 5 gene lead to
Dowling-Degos disease. Am J Hum Genet 78(3):510-9.
Ritzmann S, Hanneken S, Neumann NJ, Ruzicka T, Kruse R (2006)
Type 2 segmental manifestation of cutaneous leiomyomatosis in
four unrelated women with additional uterine leiomyomas (Reed's
Syndrome). Dermatology 212(1):84-7.
Hanneken S, Hodzic-Avdagic N, Neumann NJ, Ruzicka T,
Bruch-Gerharz D (2005) [Postpartum persistent herpes
gestationis. A therapeutic challenge]
Hautarzt 56(10):961-3.
Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J,
Brockschmidt FF, Flaquer A, Freudenberg-Hua Y, Jamra RA, Metzen
C, Heyn U, Schweiger N, Betz RC, Blaumeiser B, Hampe J,
Schreiber S, Schulze TG, Hennies HC, Schumacher J, Propping P,
Ruzicka T, Cichon S, Wienker TF, Kruse R, Nöthen MM. (2005)
Genetic Variation in the Human Androgen Receptor Gene Is the
Major Determinant of Common Early-Onset Androgenetic Alopecia.
Am J Hum Genet 77(1):140-148.
Hanneken S, Sterzinger AA, Schulte KW, Reifenberger J (2005)
[Photodynamic therapy for a nevoid basal cell carcinoma
syndrome.] Hautarzt 56:363-4.
Neumann NJ, Hanneken S, Ruzicka T, Lehmann P (2004)
Phototoxicity of exogenous protoporphyrin IX and
δ-aminolevulinic acid in the photo hen’s egg test. Photoderm
Photoimmunol Photomed 20:224-9.
Gardlo K, Hanneken S, Ruzicka T, Neumann NJ (2004)
[Photodynamic therapy of cutaneous leishmaniasis. A promising
new therapeutic modality.] Hautarzt 5(4):381-3.
Neumann NJ, Hanneken S, Ruzicka T, Schulte KW (2004) [Special
emergencies in dermatology]. Hautarzt 55(6):512-8.
Hanneken S, Kruse R, Dall P, Ruzicka T, Neumann NJ (2004)
Unilateral pseudogynecomastia: a novel work-related disease.
Ann Intern Med 140 (6):W28.
Kruse R, Schuppe HC, Malms J, Hanneken S, Ruzicka T, Neumann NJ
(2003) Anti-inflammatory and varicozele treatment in
non-obstructive azoospermia. Andrologia 35: 217-9.
Hanneken S, Ritzmann S, Nöthen MM, Kruse R (2003)
Androgenetische Alopezie: Aktuelle Aspekte eines vertrauten
Phänotyps. Hautarzt 54(8):703-12.
Hanneken S, Kruse R, Schulte KW, Ruzicka, T, Neumann, NJ (2002)
[Der diagnostische Stellenwert von Nagelveränderungen für die
allgemeinmedizinische Praxis.] Z Allg. Med 78:547-51.
Hanneken S, Kruse R, Dall P, Ruzicka T, Neumann NJ (2002)
Unilaterale Pseudogynäkomastie. Z Hautkr 76:445-61.
Asadullah K , Friedrich M , Hanneken S, Rohrbach C, Audring H,
Vergopoulos A, Ebeling M, Döcke WD, Volk HD, Sterry W (2001)
Effects of systemic interleukin-10 therapy on psoriatic skin
lesions: Histologic, immunhistologic and molecular biology
findings. J Invest Dermatol 116(5):721-27.
Asadullah K, Haeußler-Quade A, Gellrich S, Hanneken S,
Hansen-Hagge TE, Döcke WD, Volk HD, Sterry W (2000) IL-15 and
IL-16 overexpression in cutaneous T-cell lymphomas:
stage-dependent increase in mycosis fungoides progression. Exp
Dermatol 9:248-51.